Regenerative Medicine Institute (REMEDI), CÚRAM Centre for Research in Medical Devices, School of Medicine, National University of Ireland Galway, Galway, Ireland.
Nephrology Services, Galway University Hospitals, SAOLTA University Healthcare Group, Galway, Ireland.
Eur Respir J. 2019 Oct 17;54(4). doi: 10.1183/13993003.00609-2019. Print 2019 Oct.
We wished to determine the influence of sex on the management and outcomes in acute respiratory distress syndrome (ARDS) patients in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE).
We assessed the effect of sex on mortality, intensive care unit and hospital length of stay, and duration of invasive mechanical ventilation (IMV) in patients with ARDS who underwent IMV, adjusting for plausible clinical and geographic confounders.
Of 2377 patients with ARDS, 905 (38%) were female and 1472 (62%) were male. There were no sex differences in clinician recognition of ARDS or critical illness severity profile. Females received higher tidal volumes (8.2±2.1 7.2±1.6 mL·kg; p<0.0001) and higher plateau and driving pressures compared with males. Lower tidal volume ventilation was received by 50% of females compared with 74% of males (p<0.0001). In shorter patients (height ≤1.69 m), females were significantly less likely to receive lower tidal volumes. Surviving females had a shorter duration of IMV and reduced length of stay compared with males. Overall hospital mortality was similar in females (40.2%) males (40.2%). However, female sex was associated with higher mortality in patients with severe confirmed ARDS (OR for sex (male female) 0.35, 95% CI 0.14-0.83).
Shorter females with ARDS are less likely to receive lower tidal volume ventilation, while females with severe confirmed ARDS have a higher mortality risk. These data highlight the need for better ventilatory management in females to improve their outcomes from ARDS.
我们旨在通过大型观察性研究来理解严重急性呼吸衰竭的全球影响(LUNG SAFE),以确定性别对急性呼吸窘迫综合征(ARDS)患者管理和结局的影响。
我们评估了性别对接受有创机械通气(IMV)的 ARDS 患者死亡率、重症监护病房和医院住院时间以及 IMV 持续时间的影响,同时调整了可能的临床和地理混杂因素。
在 2377 名 ARDS 患者中,905 名(38%)为女性,1472 名(62%)为男性。在 ARDS 临床医生的识别和危重病严重程度特征方面,男女之间没有性别差异。女性接受的潮气量更高(8.2±2.1 与 7.2±1.6 ml·kg;p<0.0001),平台压和驱动压也高于男性。与男性相比,50%的女性接受低潮气量通气,而男性为 74%(p<0.0001)。在身材较矮小的患者(身高≤1.69 m)中,女性接受低潮气量通气的可能性明显低于男性。与男性相比,存活的女性 IMV 持续时间和住院时间更短。女性的总体医院死亡率与男性相似(40.2%对 40.2%)。然而,在严重确诊的 ARDS 患者中,女性性别与更高的死亡率相关(性别(男性对女性)的比值比为 0.35,95%可信区间为 0.14-0.83)。
患有 ARDS 的身材较矮小的女性更不可能接受低潮气量通气,而患有严重确诊 ARDS 的女性则有更高的死亡风险。这些数据强调了需要更好地对女性进行通气管理,以改善其 ARDS 结局。